Abstract
Introduction 23
Acetyl-CoA carboxylase 1 and 2 (ACC 1 and 2) catalyze the synthesis of malonyl-CoA through 24 the carboxylation of acetyl-CoA (Zempleni et al., 2012) . Malonyl-CoA synthesized from 25 cytoplasmic ACC1 and mitochondrial ACC2 serves as the C2 donor in fatty acid synthesis and 26 as a regulator of beta-oxidation of long chain fatty acids, respectively (Wakil, 1960; Wakil et al., 27 1983). Malonyl-CoA produced by ACC2 anchored in the outer mitochondrial membrane is an 28 inhibitor of carnitine palmitoyltransferase I (CPT I); the binding of carnitine to fatty acids by
29
CPT I is the rate-limiting step in mitochondrial fatty acid import for subsequent beta-oxidation 30 (McGarry and Brown, 1997) . mice fed a high fat diet or high fat/high-carbohydrate diet for 4 months had lower body weights 34 than wild-type controls (Abu-Elheiga et al., 2001; Choi et al., 2007; Oh et al., 2003) .
35
Additionally, ACC2 -/-mice exhibited an increase in glucose uptake and insulin sensitivity and a 36 decrease in triglyceride content in the liver and skeletal muscle compared with controls.
37
However, these findings are controversial. Other investigators could not reproduce the 38 differences in overall energy balance between skeletal muscle-specific and global ACC2 39 knockout (ACC2 -/-) mice compared to controls (Hoehn et al., 2010; Olson et al., 2010) . Body 40 weights and food intake were similar in ACC2 -/-and wild-type controls (Hoehn et al., 2010;  41 Olson et al., 2010) despite a decrease in malonyl-CoA levels and increased fatty acid oxidation 42 in skeletal muscle.
43
Mice lacking ACC1 are embryonically lethal (Abu-Elheiga et al., 2005) SA targets eukaryotic ACCs (Gerth et al., 1994; Vahlensieck et al., 1994) and inhibits the 55 enzymes at concentrations as low as 1 nM (Shen et al., 2004 ). Structural studies demonstrate that 56 the compound acts by binding to the biotin carboxylase domain of the ACC enzymes preventing 57 dimerization of eukaryotic ACCs (Shen et al., 2004) . Male C57BL/6 mice fed a high fat diet 58 supplemented with SA had reduced weight gain, adipose tissue and fasting plasma insulin levels 59 compared to mice fed high fat diets without SA supplementation and mice on chow control diets 60 (Schreurs et al., 2009 adipocyte biology (Student et al., 1980 (Manning et al., 1990) . Briefly, [9,10-3H(N) 
Protein expression

116
Cells were washed with PBS and lysed directly in the culture dish using 0.5 ml 117 radioimmunoprecipitation assay buffer containing 5µl protease inhibitor cocktail (Sigma, catalog 118 no. P8340). Cells were scraped off and the lysate was transferred to a 1.5-ml tube where they 
Oil Red O (ORO) staining and lipid quantitation 129
Cells were fixed with 4% paraformaldehyde and lipids were stained using ORO (Ramirez-
130
Zacarias et al., 1992). Hematoxylin was used to stain the nuclear compartment (Ross et al., 2000) .
131
Microscopy images were obtained using a Nikon groups when measured at day 16 (P>0.05) ( Fig. 2A,B) . The unexpected increase in PPARγ and
168
FABP4 mRNA expression in cells treated for the full 16 days was seen in all biological
169
replicates but was not statistically significant. Cells began accumulating lipids two days after 170 discontinuation of SA following a 14-day treatment course (Fig. 2C) .
171
To determine if SA could revert the phenotype of terminally differentiated 3T3-L1 cells by 172 downregulating the expression of PPAR and lipid droplet accumulation, cells were treated with 173 either 100 nM or 1 M SA beginning at 8 days post-differentiation and collected on Day 12.
174
There was no change in the size or the amount of lipid droplets after 4 days of SA administration 175 at either concentration when administration started on day 8 (Fig. 2D) . 
Palmitate rescue experiments
177
SA treatment caused a ~75% decrease in lipid accumulation compared with solvent controls, 178 which was partially restored by exogenous palmitate in SA-treated 3T3-L1 cells (Fig. 3A) . In 179 contrast, exogenous palmitate fully restored PPAR mRNA and FABP4 mRNA expression in
180
SA-treated cells compared to solvent controls (Fig. 3B, C) . Likewise, the expression of FABP4 181 protein was fully rescued by exogenous palmitate (Fig. 3D) palmitate restored lipid accumulation to 75% of that of the control (P<0.05; n=4) (Fig. 4A) .
191
Gene expression of PPARγ and FABP4 were increased compared with controls in cells treated 192 with 100 nM SA and with or without 200 M palmitate (Fig. 4 B, (Fig. 4 B,C) . Protein expression of FABP4 was unchanged across treatment groups at day 8 195 (Fig. 4D) control, inhibiting fatty acid oxidation by ~40% compared with controls (Fig. 5A) . There was no 207 change in ACC protein expression between the control and treatment groups (Fig. 5B) same phenomenon was reported previously with the ACC inhibitor, CABI (Levert et al., 2002) .
244
If SA was administered in later stages of differentiation, there was no change in the size or 245 amount of lipid droplets and the adipogenic genes remain unchanged. Work by Camp et al. 246 demonstrated that a novel potent antagonist, PD068235 was unable to cause de-differentiation of 247 mature adipocytes indicating that PPAR activation is minimal in differentiated adipocytes 248 (Camp et al., 2001 ).
13
The role of ACC1 in de novo lipogenesis is well established (Wakil et al., 1983) and ACC1 is 250 highly expressed in adipose tissue (Castle et al., 2009; Wakil et al., 1983) . In contrast, ACC2 is 251 abundantly expressed in skeletal muscle while mouse adipose tissue has low levels of ACC2 252 (Castle et al., 2009 ). Interestingly, we found a ~3-and ~2-fold increase in fatty acid oxidation 253 with both chronic and acute treatment of SA, respectively; this increase is comparable to those 254 achieved in other cell lines, i.e., a ~3-fold increase in HepG2 cells and a ~2-fold increase in
255
LNCaP cells (Beckers et al., 2007; Jump et al., 2011) . These results suggest that fatty acid region and results in $58.6 billion in lost productivity (Vijan et al., 2004 improved insulin sensitivity, comparable to those fed a chow control diet (Schreurs et al., 2009 ).
285
While it appears that SA protects mice from diet-induced obesity, the molecular and cellular 286 mechanisms that could be responsible for this protection were not formally tested. Our studies 287 provide one possible explanation for this observation, i.e., SA decreases fatty acid accumulation 288 and PPAR activation in adipose tissue.
289
The extent to which each ACC enzyme contributes to lipid accumulation and adipogenesis is 
Conclusions
